John Herbert Merrett
10Patents
5h-index
12Co-inventors
59Inventor score
Filing activity: Jun 13, 2001 → Apr 12, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6784166B2 | 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication. | Emerging Cross-Sectional Technologies | 138 | Expired |
| US6660721B2 | Anti-HCV nucleoside derivatives | Human Necessities | 128 | Expired |
| US7608601B2 | 4′-Substituted nucleoside derivatives as inhibitors of HCV RNA replication | Emerging Cross-Sectional Technologies | 43 | Expired |
| US8071567B2 | 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication | Emerging Cross-Sectional Technologies | 42 | Active |
| US7915232B2 | 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication | Emerging Cross-Sectional Technologies | 25 | Active |
| US6737429B2 | Pyrrole derivatives | Chemistry; Metallurgy | 1 | Expired |
| US6518293B2 | Anti-HIV imidazolone derivatives | Chemistry; Metallurgy | 0 | Expired |
| US8648054B2 | 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication | Emerging Cross-Sectional Technologies | 0 | Active |
| US7183296B2 | Anti-HIV pyrazole derivatives | Chemistry; Metallurgy | 0 | Expired |
| US6699887B2 | Anti-HIV pyrazole derivatives | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.